KRSNAA
Hospital & Healthcare Services
₹663.5
0.00 (0.00%)
Market Cap | 2,082 Cr | EPS | 17.9 | High | 667.15 | ||
Stock P/E | 36.1 | Net Profit Margin | 6.8 | Low | 645.65 |
Performance
Today’s Low
Today’s High
645.65
667.15
52W Low
52W High
353.1
727
Open Price | 655.35 | Volume | 426 |
Prev. Close | 645.65 |
Fundamentals
Market Cap | 2,082 Cr | ROE | 8.8% | ||
P/E Ratio(TTM) | 36.1 | EPS(TTM) | 0.0 | ||
P/B Ratio | 2.8 | Dividend Yield | 0.4% | ||
Industry P/E | 72.1 | Book Value | 234.0 | ||
Face Value | 5.0 |
About the Company
Krsnaa Diagnostics is one of the largest differentiated diagnostic service provider in India. It provides a range of technology-enabled diagnostic services such as imaging (including radiology), pathology/clinical laboratory and tele-radiology services to public and private hospitals, medical colleges and community health centres pan-India. It also operate one of India’s largest tele-radiology reporting hubs in Pune that is able to process large volumes of X-rays, CT scans and MRI scans round the clock and 365 days a year, and allows it to serve patients in remote locations where diagnostic facilities are limited. It provides quality and inclusive diagnostic services at affordable rates across various segments.
The company offers range of diagnostics imaging services and clinical laboratory tests that include both routine and specialized tests / studies and profiles, which are used for prediction, early detection, diagnostic screening, confirmation and/or monitoring of diseases. Its diagnostic imaging/radiology services include conducting X-rays, computed tomography (CT) scans, magnetic resonance imaging (MRI) scans, ultrasounds, bone mineral densitometry and mammography. In its pathology segment, its primary focus includes biochemistry, haematology, clinical pathology, histopathology and cytopathology, microbiology, serology and immunology. A suite of diagnostic equipment is located at its tele-radiology hub along with a team of radiologists which provide it significant operating efficiencies and scalability.
Business area of the company
Krsnaa Diagnostics is one of the fastest-growing diagnostic chains in India. The company offers a wide range of diagnostic services such as imaging/radiology services (X-rays, MRI, etc.), routine clinical laboratory tests, pathology, and tele-radiology services to private and public hospitals, medical colleges, and community health centres.
Key awards, accreditations or recognitions
- 2016: Star of Asia Award for Health Excellence at the 10th International Seminar of the Indian Achievers Forum.
- 2017: Emerging Company Award for Health Excellence at the 42nd National Seminar of the Indian Achiever’s Awards.
- 2019: India’s Greatest Brands Award for Healthcare and Diagnostics by Asia One.
- 2020: Best Diagnostic and Imaging Centre of the Year (Asia) at the Asia Healthcare Summit and Awards.
- 2020: Best Diagnostics Service Company of the Year at the India Excellence Awards by ET Now.
- 2020: Outstanding Achievement Award in Healthcare Social Causes at the India Excellence Awards by ET Now.
Major events and milestones
- 2011: Incorporation of the company with two radiology centres.
- 2013: Started operating 12 centres in Himachal Pradesh in public private partnership.
- 2016: Investment by Somerset and Kitara in the Company.
- 2017: Completed installation of 50 centres in four states.
- 2018: Expanded operations across 13 states.
- 2019: Received accreditation from NABH for a centre in Madhya Pradesh.
- 2019: Investment by Phi Capital in the company.
- 2020 Received accreditation from NABH and NABL for certain centres in Maharashtra.
- 2020: Expanded to over 1,500 centres across India.
- 2020: Received accreditation from NABL for certain centres in Rajasthan.
Parent Organization | Krsnaa Diagnostics Ltd. | Managing Director | Pallavi Bhatevara | ||
Founded | 2010 | NSE Symbol | KRSNAA |
Financials
All values are in Rs Cr
Shareholding Pattern
Domestic Institutions
57.15%
Foreign Institutions
4.06%
Mutual Funds
10.99%
Promoters
27.80%
Domestic Institutions
57.15%
Foreign Institutions
4.06%
Mutual Funds
10.99%
Promoters
27.80%
Domestic Institutions
57.15%
Foreign Institutions
4.06%
Mutual Funds
10.99%
Promoters
27.80%
Domestic Institutions
57.15%
Foreign Institutions
4.06%
Mutual Funds
10.99%
Promoters
27.80%
Domestic Institutions
57.15%
Foreign Institutions
4.06%
Mutual Funds
10.99%
Promoters
27.80%
Peer Comparison
Company | 52 Week | Market Price | P/E Ratio | Financials | Share Holding |
---|---|---|---|---|---|
663.5(2.8%) | 36.1 | ||||
209.35(-0.6%) | 18.6 | ||||
169.3(-1.4%) | 52.3 | ||||
566.35(1.1%) | 45.4 |